Checkpoint Therapeutics Inc. - CKPT Company Long-Term Liabilities

Checkpoint Therapeutics Inc. - graphic logo of issuer CKPT

Checkpoint Therapeutics (CKPT) is protected by exclusive rights to cosibelimab antibodies and high testing costs under strict FDA supervision. The asset's market valuation trend on GURU.Markets, where the indicator stands at 0.00, confirms an outsourcing model for production and trials to maintain flexibility. Checkpoint Therapeutics (CKPT) is focusing on finding a distribution partner to launch its primary oncology drug while ignoring mergers.

CKPT (checkpointtx.com) Company Long-Term Debt history from 07/04/2022 to 06/07/2025

Checkpoint Therapeutics, Inc - analytical breakdowns and key metrics (CKPT)

- price and consensus price forecast:
Share Price checkpointtx.com|CKPT - Analyst Consensus Forecast
- market capitalization data:
Market Valuation Checkpoint Therapeutics|CKPT - Enterprise Value
- book capitalization data:
Net Asset Value per Share Checkpoint Therapeutics|CKPT - Company Book Value|Market Value to Book Value checkpointtx.com|CKPT - Cumulative Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Checkpoint Therapeutics|CKPT - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Checkpoint Therapeutics Inc|CKPT - Company Total Debt|Debts to Book Capitalization Checkpoint Therapeutics|CKPT - Company Long-Term Debt|Company Short-Term Loans and Borrowings Checkpoint Therapeutics
Summary company analytics:checkpointtx.com (CKPT)
Original product of Checkpoint Therapeutics

This indicator captures the total volume of credit obligations with a maturity of more than one year. The metric is calculated by summing long-term loans and bonds to determine the financial stability of the capital structure. By analyzing the firm's long-term debt, an investor sees the current value of 0.00. For Checkpoint Therapeutics (CKPT), a low debt level is critical given fixed R&D expenses. An asset-light strategy utilizing contract manufacturing minimizes the need for borrowed funds.

Analysis of competing companies

Company Long-Term Indebtedness beigene.com ONC|HALO: Company Long-Term Debts|RVMD - Company Long-Term Liabilities|Company Long-Term Debts AAPG|CGON (CG Oncology Therapeutics) - Long-Term Debt|URGN - Company Long-Term Debt|Company Long-Term Loans and Borrowings bicara.com (BCAX)|Personalis (PSNL) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Erasca Inc (ERAS)|Delcath - Company Long-Term Debts|YMAB - Company Long-Term Liabilities|Aura Biosciences, Inc. - Company Long-Term Liabilities|CADL: Company Long-Term Debts|Company Long-Term Debt Accuray ARAY|SELLAS Life Sciences Group (SLS) - Company Long-Term Loans and Borrowings|Company Long-Term Debts ACTU (Actuate Therapeutics, Inc)|Long-Term Debt Citius Oncology Inc|Company Long-Term Debts HURA (TuHURA Biosciences, Inc.)|Company Long-Term Liabilities protaratx.com (TARA)|Company Long-Term Debts Fate Therapeutics|Company Long-Term Loans and Borrowings Aadi Bioscience, Inc. WHWK|TCRX (TScan) - Company Long-Term Debts|CSBR - Long-Term Debt|XBIT (xbiotech.com) - Company Long-Term Debts|CVM (CEL-SCI) - Company Long-Term Liabilities|OSTX (OS Therapies) - Company Long-Term Debt|Company Long-Term Debts RADX|ARTV - Company Long-Term Debt|Long-Term Liabilities ANL (adlainortye.com)|VERU: Company Long-Term Debt|Long-Term Debt tempesttx.com TPST|Company Long-Term Debts XLO (Xilio)|RENB: Long-Term Debt Volume|Company Long-Term Debt muraloncology.com|Company Long-Term Indebtedness Kairos Pharma|OnKure Therapeutics, Inc. (OKUR) - Company Long-Term Liabilities|Amount of Long-Term Liabilities CytoMed (GDTC)|Curis, Inc. (CRIS) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings apollomicsinc.com APLM|Company Long-Term Liabilities Tharimmune Corp (THAR)|Amount of Long-Term Liabilities Advanced Biomed Inc. ADVB|Company Long-Term Debts Genprex, Inc. (GNPX)|CLDI - Company Long-Term Loans and Borrowings|Company Long-Term Debts SBFM|XBIO (Xenetic Biosciences, Inc.) - Long-Term Debt|SLRX - Company Long-Term Debt|Company Long-Term Loans and Borrowings Kitov Pharma|Company Long-Term Debts AONC|Company Long-Term Debts BGNE (beigene.com)|Elevation Oncology, Inc. (ELEV) - Company Long-Term Debt|Long-Term Liabilities iCAD Inc. ICAD|IKNA (Ikena) - Company Long-Term Debts|Notable Labs Corp (NTBL) - Long-Term Debt|VIRX: Company Long-Term Liabilities|Company Long-Term Debts morphosys.com|NAYA Biosciences Inc. (NAYA) - Company Long-Term Liabilities|Amount of Long-Term Liabilities Ascentage Pharma Group International